TWD
EDIT icon

True Wealth Design’s Editas Medicine EDIT Stock Holding History

True Wealth Design’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33K Buy
412
+80
+24% +$234 ﹤0.01% 1875
2026
Q1 		$821 Buy
332
+188
+131% +$398 ﹤0.01% 1877
2025
Q4 		$296 Buy
144
+15
+12% +$43 ﹤0.01% 2125
2025
Q3 		$448 Hold
129
– – ﹤0.01% 2046
2025
Q2 		$284 Sell
129
-1,460
-92% -$2.39K ﹤0.01% 1962
2025
Q1 		$1.84K Buy
1,589
+1,246
+363% +$1.83K ﹤0.01% 1038
2024
Q4 		$436 Buy
343
+223
+186% +$568 ﹤0.01% 1117
2024
Q3 		$410 Buy
+120
New +$522 ﹤0.01% 1128

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

True Wealth Design's EDIT Position: Q2 2026 in Review

True Wealth Design increased its Editas Medicine (EDIT) stake by 24% in Q2 2026, buying an estimated $234 and bringing the position to 412 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #1875.

True Wealth Design first reported a position in EDIT in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.84K in Q1 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • True Wealth Design held 412 shares of Editas Medicine worth $1.33K as of Q2 2026.
  • True Wealth Design bought 80 Editas Medicine shares in Q2 2026, an estimated $234.
  • Editas Medicine made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1875 holding.
  • True Wealth Design first reported a position in Editas Medicine in Q3 2024 and has held it in 8 quarters since.
  • True Wealth Design's Editas Medicine position peaked at $1.84K in Q1 2025.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.